Tag: carmot therapeutics

Sleep duration inversely related to childhood type 2 diabetes risk makers

Roche: CT-388 Dual GLP1-GIP Receptor Agonist Clinically Improves Weight Loss

byAdrian Cheand1 others

May 27, 2024

Patients who received CT-388 had an average placebo-adjusted weight loss of 18.8%. CT-388 is well tolerated with only mild to ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Artificial intelligence (AI)-powered mental health app demonstrated improved social well-being among users
Children with intellectual and developmental disabilities have increased risks of depression and anxiety
Gabapentin (Neurontin) prescription for chronic low back pain in adults is associated with a higher risk of dementia

No Result

View All Result

Tag: carmot therapeutics

Roche: CT-388 Dual GLP1-GIP Receptor Agonist Clinically Improves Weight Loss

2MM+ All Access

Look up any US clinician

Recent Reports

The medical literature, distilled daily.

Membership benefits